The present disclosure relates to a compound of formula (I), or a pharmaceutically acceptable salt, a solvate, a stereoisomer, or tautomer thereof, a pharmaceutical composition comprising a compound of formula (A) or formula (B), and any subgenera thereof, and use of said compounds and compositions thereof, wherein R1, R2, R3a, R3b, R5, R6, X1, X2, Y and n are described herein.or；本發明係關於式(I)化合物或其醫藥上可接受之鹽、溶劑合物、立體異構物或互變異構物、包含式(A)或式(B)及其任何亞屬之化合物之醫藥組合物，及該等化合物及其組合物之用途，其中R1、R2、R3a、R3b、R5、R6、X1、X2、Y及n闡述於本文中或。
